Array
(
    [id] => chatcmpl-AipZ8E7CnNBnHxuEeLPa1Cvjz1TvT
    [object] => chat.completion
    [created] => 1735248014
    [model] => gpt-4o-mini-2024-07-18
    [choices] => Array
        (
            [0] => Array
                (
                    [index] => 0
                    [message] => Array
                        (
                            [role] => assistant
                            [content] => - *!A study assessed the effects of extended intervals between COVID-19 vaccine doses, focusing on the ChAdOx1 nCoV-19 vaccine, amid concerns over vaccine supply and potential immunity loss in some countries.*!  
- *!Volunteers aged 18-55 were invited to evaluate immune responses after receiving either a delayed second dose (44-45 weeks later) or a third booster dose (28-38 weeks after the second), with a focus on measuring reactogenicity and immunogenicity.*!  
- *!The findings indicate that a significant percentage of participants were eligible for assessing immune responses, which will help understand the effectiveness of various dosing schedules in maintaining immunity against COVID-19.*!
                            [refusal] => 
                        )

                    [logprobs] => 
                    [finish_reason] => stop
                )

        )

    [usage] => Array
        (
            [prompt_tokens] => 569
            [completion_tokens] => 144
            [total_tokens] => 713
            [prompt_tokens_details] => Array
                (
                    [cached_tokens] => 0
                    [audio_tokens] => 0
                )

            [completion_tokens_details] => Array
                (
                    [reasoning_tokens] => 0
                    [audio_tokens] => 0
                    [accepted_prediction_tokens] => 0
                    [rejected_prediction_tokens] => 0
                )

        )

    [system_fingerprint] => fp_0aa8d3e20b
)